Iopidine

Apraclonidine, the active ingredient in Iopidine, is a alpha-2 adrenergic agonist presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with glaucoma or ocular hypertension.

GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iopidine is an ocular hypotensive agent used in the management of conditions that raise intra‑ocular pressure.

- Glaucoma: reduces intra‑ocular pressure to help preserve visual field. - Ocular hypertension: lowers pressure in eyes without established glaucomatous damage. - Secondary ocular hypertension: controls pressure elevation secondary to ocular inflammation or trauma.

Adverse reactions are generally mild to moderate, but serious events can occur.

Common Side Effects: - Burning or stinging sensation at the instillation site. - Redness of the conjunctiva. - Blurred vision shortly after dosing. - Dry eye sensation.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid. - Severe eye pain or corneal edema. - Persistent visual disturbance. - Systemic hypotension or bradycardia. - Rare cases of arrhythmia.

Use Iopidine only under the direction of an eye‑care professional and observe the following precautions.

- Monitor intra‑ocular pressure: ensure adequate pressure reduction and adjust therapy as needed. - Cardiovascular disease: use with caution in patients with hypotension or bradycardia. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Concomitant ocular drugs: avoid unsupervised combination with other pressure‑lowering eye drops. - Storage: Store at room temperature: keep in the original container, protect from light and moisture.

Apraclonidine may interact with other systemic or ocular agents.

Major Interactions (Avoid): - Systemic alpha‑2 agonists (e.g., clonidine): may cause additive hypotensive effects. - MAO inhibitors: increased risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Topical beta‑blocker eye drops: potential for excessive IOP lowering. - Prostaglandin analogues: may require dose adjustment. - Oral antihypertensive medications: monitor blood pressure for additive effects.